These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12565872)

  • 1. Cloning and characterization of a functional promoter of the human SOCS-3 gene.
    He B; You L; Uematsu K; Matsangou M; Xu Z; He M; McCormick F; Jablons DM
    Biochem Biophys Res Commun; 2003 Feb; 301(2):386-91. PubMed ID: 12565872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of the suppressor of cytokine signaling-3 promoter in human non-small-cell lung cancer.
    He B; You L; Xu Z; Mazieres J; Lee AY; Jablons DM
    Clin Lung Cancer; 2004 May; 5(6):366-70. PubMed ID: 15217536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of expression of the rat SOCS-3 gene in hepatocytes by growth hormone, interleukin-6 and glucocorticoids mRNA analysis and promoter characterization.
    Paul C; Seiliez I; Thissen JP; Le Cam A
    Eur J Biochem; 2000 Oct; 267(19):5849-57. PubMed ID: 10998044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction.
    Nicholson SE; Willson TA; Farley A; Starr R; Zhang JG; Baca M; Alexander WS; Metcalf D; Hilton DJ; Nicola NA
    EMBO J; 1999 Jan; 18(2):375-85. PubMed ID: 9889194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter.
    Auernhammer CJ; Bousquet C; Melmed S
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6964-9. PubMed ID: 10359822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
    Bousquet C; Susini C; Melmed S
    J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary corticotroph SOCS-3: novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion.
    Auernhammer CJ; Chesnokova V; Bousquet C; Melmed S
    Mol Endocrinol; 1998 Jul; 12(7):954-61. PubMed ID: 9658400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
    Lejeune D; Demoulin JB; Renauld JC
    Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cAMP neuropeptide agonists induce pituitary suppressor of cytokine signaling-3: novel negative feedback mechanism for corticotroph cytokine action.
    Bousquet C; Chesnokova V; Kariagina A; Ferrand A; Melmed S
    Mol Endocrinol; 2001 Nov; 15(11):1880-90. PubMed ID: 11682619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The suppressors of cytokine signalling (SOCS).
    Kile BT; Alexander WS
    Cell Mol Life Sci; 2001 Oct; 58(11):1627-35. PubMed ID: 11706989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressors of cytokine signaling (SOCS): inhibitors of the JAK/STAT pathway.
    Cooney RN
    Shock; 2002 Feb; 17(2):83-90. PubMed ID: 11837794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
    Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
    Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma.
    Niwa Y; Kanda H; Shikauchi Y; Saiura A; Matsubara K; Kitagawa T; Yamamoto J; Kubo T; Yoshikawa H
    Oncogene; 2005 Sep; 24(42):6406-17. PubMed ID: 16007195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing.
    Bousquet C; Zatelli MC; Melmed S
    J Clin Invest; 2000 Dec; 106(11):1417-25. PubMed ID: 11104795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A family of cytokine-inducible inhibitors of signalling.
    Starr R; Willson TA; Viney EM; Murray LJ; Rayner JR; Jenkins BJ; Gonda TJ; Alexander WS; Metcalf D; Nicola NA; Hilton DJ
    Nature; 1997 Jun; 387(6636):917-21. PubMed ID: 9202125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent roles of SOCS-3 and SHP-2 in the regulation of neuronal gene expression by leukemia inhibitory factor.
    Bartoe JL; Nathanson NM
    Brain Res Mol Brain Res; 2002 Nov; 107(2):108-19. PubMed ID: 12425940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) stimulates corticotroph function via a signal transducer and activator of transcription-dependent mechanism negatively regulated by suppressor of cytokine signaling-3.
    Auernhammer CJ; Isele NB; Kopp FB; Spoettl G; Cengic N; Weber MM; Senaldi G; Engelhardt D
    Endocrinology; 2003 Apr; 144(4):1202-10. PubMed ID: 12639901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JAK/STAT3 pathway is involved in survival of neurons in response to insulin-like growth factor and negatively regulated by suppressor of cytokine signaling-3.
    Yadav A; Kalita A; Dhillon S; Banerjee K
    J Biol Chem; 2005 Sep; 280(36):31830-40. PubMed ID: 15998644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Jak-Stat and MAPK2 pathways by oncostatin M leads to growth inhibition of human glioma cells.
    Halfter H; Friedrich M; Postert C; Ringelstein EB; Stögbauer F
    Mol Cell Biol Res Commun; 1999 May; 1(2):109-16. PubMed ID: 10356359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer.
    He B; You L; Uematsu K; Zang K; Xu Z; Lee AY; Costello JF; McCormick F; Jablons DM
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14133-8. PubMed ID: 14617776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.